Dec. 18, 2014

Corporate Advisory Council Provides Industry Perspective to Bringing Down Scientific Barriers


The Lupus Foundation of America's Corporate Advisory Council (CAC) is a collaboration of biotechnology and pharmaceutical industry representatives formed by the Foundation to advance its goal of stimulating development of an arsenal of treatments for lupus and getting them to the people who need them.

The CAC recently marked its tenth anniversary of working to address issues in lupus drug development. Rick Goulburn, Executive Vice President of Vifor Pharma co-chairs the Council. In this video he discusses how the LFA-CAC partnership is advancing the science and medicine of lupus and bringing down barriers to securing approval of new, more tolerable and effective therapies for lupus.

Related Stories

Video | Jul. 19, 2013

Why Lupus is a Cruel Mystery

Learn what makes lupus so different from many other diseases and why lupus is a cruel mystery.

Video | Jan. 15, 2009

Target Awareness: Lupus

An introduction to lupus and the services of the Lupus Foundation of America.